Harmony Biosciences Holdings, Inc. Announces Commencement of Proposed Public Offering of Common Stock by Selling Shareholders

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. HOOD
10. ABBV

Go back to Harmony Biosciences Holdings, Inc. Announces Commencement of Proposed Public Offering of Common Stock by Selling Shareholders

Goldman Sachs Reiterates Sell Rating on Harmony Biosciences Holdings Inc. (HRMY)

October 30, 2024 6:10 AM EDT

Goldman Sachs analyst Corinne Jenkins reiterated a Sell rating and $28.00 price target on Harmony Biosciences Holdings Inc. (NASDAQ: HRMY)

The analyst comments "HRMY is finished the trading day higher (16% vs 0% XBI) after reporting 3Q24 product revenues of $186.0M, 1%/1% vs. FactSet consensus and GS estimates of $184.1M/$184.0M. The company reported average patients on therapy at ~6,800 vs. 6,550 during 2Q24, a 250... More